LACRIMATION AND 5-FLUOROURACIL

被引：14

作者：

CHRISTOPHIDIS, N ^{[1
]}

VAJDA, FJE ^{[1
]}

LOUIS, WJ ^{[1
]}

机构：

[1] AUSTIN HOSP, CLIN PHARMACOL & THERAPEUT UNIT, HEIDELBERG 3084, VICTORIA, AUSTRALIA

来源：

关键词：

D O I：

10.7326/0003-4819-89-4-574_1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：574 / 574

页数：1

共 5 条

[1] FLUOROURACIL THERAPY IN PATIENTS WITH CARCINOMA OF LARGE BOWEL - PHARMACOKINETIC COMPARISON OF VARIOUS RATES AND ROUTES OF ADMINISTRATION
CHRISTOPHIDIS, N
VAJDA, FJE
LUCAS, I
DRUMMER, O
MOON, WJ
LOUIS, WJ
[J]. CLINICAL PHARMACOKINETICS, 1978, 3 (04) : 330 - 336
[2] CHRISTOPHIDIS N, P AUST SOC CLIN EXP
[3] TEAR-DUCT FIBROSIS (DACRYOSTENOSIS) DUE TO 5-FLUOROURACIL
HAIDAK, DJ
HURWITZ, BS
YEUNG, KY
[J]. ANNALS OF INTERNAL MEDICINE, 1978, 88 (05) : 657 - 657
[4] HAMERSLEY J, 1973, JAMA-J AM MED ASSOC, V225, P748
[5] TREATMENT OF BASAL-CELL EPITHELIOMAS AND ACTINIC KERATOSES
JANSEN, GT
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (11): : 1152 - 1154